
The FDA is requiring new labeling across all GLP-1 receptor agonists to warn of a potential increased risk of a rare, vision-threatening optic nerve condition.
Research from AES 2016 explored relationships between epilepsy and other neurological disorders, including Alzheimer disease, MS, stroke, and autism.
Research presented during AES 2016 explored the relationship between epilepsy and other neurological disorders, including Alzheimer disease, multiple sclerosis, stroke, autism, and more.



